Varicella Live Vaccine Market Overview

Global Varicella Live Vaccine Market Expected to Reach $4,222 Million by 2026

PORTLAND, OREGON, UNITED STATE, March 31, 2022 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, "Varicella Live Vaccine Market by Product, Application, and Provider: Global Opportunity Analysis and Industry Forecast, 2018-2026," the global varicella live vaccine market was valued at $2.71 billion in 2018, and is expected to reach $4.22 billion by 2026, registering a CAGR of 5.7% from 2019 to 2026.

Download Sample Report : https://www.alliedmarketresearch.com/request-sample/3969

Rise in immunization programs worldwide is the major factor that boost the growth of the varicella live vaccine market. In addition, factors such as surge in awareness related to the use of varicella live vaccines and increase in adoption of varicella vaccination across the globe fuel the growth of the varicella live vaccine market. However, high monetary inputs associated with manufacture of the products restrict the growth of the market. Conversely, growth potential in emerging economies is expected to create lucrative opportunities for the market during the forecast period.

Based on product, the monovalent varicella vaccine segment acquired the major share of the varicella live vaccine market and is expected to experience rapid growth during the forecast period as these vaccines exhibit lesser chances of inducing febrile seizures in children as compared to combination vaccines. Moreover, easy availability and presence of large number of products is another reason that boosts the growth of the monovalent varicella vaccine market.

Based on application, chicken pox immunization acquired the largest share of the varicella live vaccine market owing to vaccination employed with an initial aim of building immunity against chicken pox. Herpes zoster segment is expected to grow at the fastest rate during the forecast period owing to surge in geriatric population worldwide and rise in awareness about the use of varicella live vaccines for herpes zoster.

On the basis of region, North America acquired a major share owing to easy availability of varicella live vaccines, presence of skilled healthcare experts, and presence of major key players that offer varicella live vaccines. Asia-Pacific is expected to grow at the fastest rate during the forecast period due to surge in awareness related to importance of immunization and rise in disposable income.

Key Findings of The Varicella Live Vaccine Market:

Monovalent varicella vaccine occupied two-thirds share of the global varicella live vaccine market in 2018
The herpes zoster segment is anticipated to grow with the highest CAGR throughout the forecast period
The private segment accounted for two-third share of the market in 2018

Key Market Segments

BY PRODUCT
Monovalent Varicella Vaccine
Combination Varicella Vaccine

BY APPLICATION
Chickenpox Immunization
Herpes Zoster Immunization
Mumps, measles, rubella & varicella (MMRV) Immunization

BY PROVIDER
Public
Private

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/3969

Other Trending Reports:

Digital Wound Measurement Devices Market

Refurbished DNA Sequencing Platforms Market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn